Key statistics
As of last trade Immutep Ltd (YP1A:DUS) traded at 2.26, -16.30% below its 52-week high of 2.70, set on Dec 29, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.26 |
|---|---|
| High | 2.26 |
| Low | 2.26 |
| Bid | 2.28 |
| Offer | 2.34 |
| Previous close | 2.30 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 147.37m |
| Free float | 124.24m |
| P/E (TTM) | -- |
| Market cap | 390.94m USD |
| EPS (TTM) | -0.2984 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 15:30 GMT.
More ▼
Announcements
- Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
- Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer
- Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
